| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.693 | 223.737 | 240.973 | 186.652 | 127.326 | 55.942 | 15.558 | 0 | 0 | 0 |
| Total Income - EUR | 53.452 | 224.471 | 244.209 | 188.294 | 131.856 | 58.385 | 19.040 | 4.055 | 0 | 0 |
| Total Expenses - EUR | 24.038 | 110.833 | 170.328 | 139.776 | 116.202 | 84.242 | 30.338 | 2.704 | 473 | 0 |
| Gross Profit/Loss - EUR | 29.414 | 113.638 | 73.880 | 48.517 | 15.654 | -25.857 | -11.298 | 1.351 | -473 | 0 |
| Net Profit/Loss - EUR | 24.681 | 98.099 | 62.028 | 46.793 | 14.379 | -26.319 | -11.782 | 1.229 | -473 | 0 |
| Employees | 2 | 3 | 3 | 3 | 4 | 4 | 2 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Vesmaş & Partner Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 54 | 8.127 | 24.871 | 17.507 | 11.981 | 3.309 | 0 | 0 | 0 | 0 |
| Current Assets | 45.801 | 103.462 | 100.131 | 67.601 | 55.282 | 25.299 | 1.771 | 1.401 | 1.457 | 1.449 |
| Inventories | 314 | 457 | 0 | 162 | 621 | 62 | 0 | 0 | 0 | 0 |
| Receivables | 2.452 | 4.640 | 45.717 | 50.304 | 32.195 | 17.435 | 1.722 | 1.235 | 1.327 | 1.319 |
| Cash | 43.035 | 98.365 | 54.414 | 17.136 | 22.465 | 7.802 | 49 | 166 | 130 | 129 |
| Shareholders Funds | 43.300 | 99.435 | 83.987 | 48.082 | 39.143 | 6.068 | -5.848 | -4.637 | -5.096 | -5.068 |
| Social Capital | 1.350 | 1.336 | 1.313 | 1.289 | 1.264 | 1.240 | 1.213 | 1.217 | 1.213 | 1.206 |
| Debts | 2.555 | 12.154 | 41.015 | 37.026 | 28.119 | 22.540 | 7.619 | 6.038 | 6.553 | 6.517 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7810 - 7810" | |||||||||
| CAEN Financial Year |
7810
|
|||||||||
Comments - Dr. Vesmaş & Partner Srl